Related references
Note: Only part of the references are listed.Phase II Open-Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease
Isabelle Kone-Paut et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study
Jackeline J. Rodriguez-Smith et al.
LANCET RHEUMATOLOGY (2021)
Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management
Matthew L. Dove et al.
JOURNAL OF PEDIATRICS (2021)
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial
Hermine I. Brunner et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe
Israel Valverde et al.
CIRCULATION (2021)
SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment
Nahed Abdel-Haq et al.
EUROPEAN JOURNAL OF PEDIATRICS (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Xavier Mariette et al.
LANCET RESPIRATORY MEDICINE (2021)
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Leora R. Feldstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children
Naim Ouldali et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth
Danielle M. Fernandes et al.
JOURNAL OF PEDIATRICS (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
Kerri L. LaRovere et al.
JAMA NEUROLOGY (2021)
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
Michelle Sholzberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C
Hilary Whitworth et al.
BLOOD (2021)
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 The HEP-COVID Randomized Clinical Trial
Alex C. Spyropoulos et al.
JAMA INTERNAL MEDICINE (2021)
Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease
Ana Esteve-Sole et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19 A Randomized Clinical Trial
Roberto Caricchio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Patrick R. Lawler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Treatment of Multisystem Inflammatory Syndrome in Children
Andrew J. McArdle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Patricia O. Guimaraes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes
Mary Beth F. Son et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Ewan C. Goligher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Bayesian Model to Predict COVID-19 Severity in Children
Sara Dominguez-Rodriguez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)
IVIG Compared With IVIG Plus Infliximab in Multisystem Inflammatory Syndrome in Children
Lyndsey D. Cole et al.
PEDIATRICS (2021)
Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England
Defne Saatci et al.
JAMA PEDIATRICS (2021)
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial
Vincent C. Marconi et al.
LANCET RESPIRATORY MEDICINE (2021)
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
Amanda B. Payne et al.
JAMA NETWORK OPEN (2021)
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Esraa M. Eloseily et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Recognition and Initial Management of Fulminant Myocarditis A Scientific Statement From the American Heart Association
Robb D. Kociol et al.
CIRCULATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic
Zahra Belhadjer et al.
CIRCULATION (2020)
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner et al.
GASTROENTEROLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City
Jerry Y. Chao et al.
JOURNAL OF PEDIATRICS (2020)
Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region
Roberta L. DeBiasi et al.
JOURNAL OF PEDIATRICS (2020)
Thromboinflammation and the hypercoagulability of COVID-19
Jean M. Connors et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report
Bo Zhou et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Hyperinflammatory shock in children during COVID-19 pandemic
Shelley Riphagen et al.
LANCET (2020)
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Lucio Verdoni et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
Lara S. Shekerdemian et al.
JAMA PEDIATRICS (2020)
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children
Marion Grimaud et al.
ANNALS OF INTENSIVE CARE (2020)
Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series
Kathleen Chiotos et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Children with Covid-19 in Pediatric Emergency Departments in Italy
Niccolo Parri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Infection in Children
Xiaoxia Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Epidemiology of COVID-19 Among Children in China
Yuanyuan Dong et al.
PEDIATRICS (2020)
SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children
Francesco Licciardi et al.
PEDIATRICS (2020)
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort
Marie Pouletty et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19-COVID-NET, 14 States, March 1-July 25, 2020
Lindsay Kim et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
Elizabeth Whittaker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
Eva W. Cheung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Septic shock presentation in adolescents with COVID-19
Cecilia Dallan et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
The severity of COVID-19 in children on immunosuppressive medication
Matko Marlais et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition
Dan Turner et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Characteristics, Cardiac Involvement, and Outcomes of Multisystem Inflammatory Disease of Childhood (MIS-C) Associated with SARS-CoV-2 Infection
Christine A. Capone et al.
JOURNAL OF PEDIATRICS (2020)
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City
Shubhi Kaushik et al.
JOURNAL OF PEDIATRICS (2020)
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review
Joseph Y. Abrams et al.
JOURNAL OF PEDIATRICS (2020)
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
Luca Carsana et al.
LANCET INFECTIOUS DISEASES (2020)
Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)
Conor N. Gruber et al.
CELL (2020)
Multisystem Inflammatory Syndrome in US Children and Adolescents
Leora R. Feldstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Multisystem Inflammatory Syndrome in Children in New York State
Elizabeth M. Dufort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Xabier Michelena et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
Julie Toubiana et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children
Pui Y. Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS CoV-2
Caroline Diorio et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection
Michael J. Carter et al.
NATURE MEDICINE (2020)
Atrioventricular Block in Children With Multisystem Inflammatory Syndrome
Audrey Dionne et al.
PEDIATRICS (2020)
Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020
Sapna Bamrah Morris et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children
Zahra Belhadjer et al.
CIRCULATION (2020)
Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry
Matthew D. Elias et al.
CJC OPEN (2020)
COVID-19-Associated Pediatric Multisystem Inflammatory Syndrome
Maria Paz Deza Leon et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016
Nobuko Makino et al.
PEDIATRICS INTERNATIONAL (2019)
Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study
Nienke M. ter Haar et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis
Chun-Yu Yen et al.
SCIENTIFIC REPORTS (2019)
A Pilot Study of the Association of Amino-Terminal Pro-B-Type Natriuretic Peptide and Severity of Illness in Pediatric Septic Shock
Elliot Melendez et al.
PEDIATRIC CRITICAL CARE MEDICINE (2019)
High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant
Marie Lind-Holst et al.
BMJ CASE REPORTS (2019)
The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series
Isabelle Kone-Paut et al.
AUTOIMMUNITY REVIEWS (2018)
Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm
Marie-Paule Guillaume et al.
CARDIOLOGY IN THE YOUNG (2018)
Stenotic Lesions and the Maximum Diameter of Coronary Artery Aneurysms in Kawasaki Disease
Etsuko Tsuda et al.
JOURNAL OF PEDIATRICS (2018)
Adjunctive Glucocorticoid Therapy in Patients with Septic Shock
B. Venkatesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial
Masaaki Mori et al.
SCIENTIFIC REPORTS (2018)
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
Nicolino Ruperto et al.
PEDIATRIC RHEUMATOLOGY (2017)
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
Gerd Horneff et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle et al.
CIRCULATION (2017)
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population
Kevin G. Friedman et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
Hermine I. Brunner et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study
Puja Banka et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Thrombosis and embolism in pediatric cardiomyopathy
Kai Chen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2013)
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease A Scientific Statement From the American Heart Association
Therese M. Giglia et al.
CIRCULATION (2013)
The Why and How of Z Scores
Steven D. Colan
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2013)
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
Tohru Kobayashi et al.
LANCET (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
Shohei Ogata et al.
PEDIATRICS (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load
Robert Dennert et al.
ANTIVIRAL THERAPY (2010)
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
Leo Lopez et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2010)
Treatment of Kawasaki Disease: Analysis of 27 US Pediatric Hospitals From 2001 to 2006
Mary Beth F. Son et al.
PEDIATRICS (2009)
Recognition of a Kawasaki Disease Shock Syndrome
John T. Kanegaye et al.
PEDIATRICS (2009)
Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: Series of six patients and review of literature
Sorel Goland et al.
CANADIAN JOURNAL OF CARDIOLOGY (2008)
Assessment of B-type natriuretic peptide in patients with pneumonia
O. Yetkin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease
Jane W. Newburger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome
Yoshinari Inoue et al.
JOURNAL OF PEDIATRICS (2006)
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association
JW Newburger et al.
PEDIATRICS (2004)
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000
RC Holman et al.
PEDIATRICS (2003)
Share Paper
